LINC00958 and neoplasm: Taken together, this study reported a new regulatory axis linc00958/miR-185-5p/RSF-1 in cisplatin resistance and tube formation in CC via AKT1/GSK3β/VEGFA pathway and knockdown of linc00958 could also inhibit the tumor growth and angiogenesis.